JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, T. J.
Right arrow Articles by Duffy, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, T. J.
Right arrow Articles by Duffy, L. L.
Anesth Analg 2000;91:596-600
© 2000 International Anesthesia Research Society


AMBULATORY ANESTHESIA

Spontaneous Recovery Profile of Rapacuronium During Desflurane, Sevoflurane, or Propofol Anesthesia for Outpatient Laparoscopy

Tian J. Zhou, MD*, Margarita Coloma, MD*, Paul F. White, PhD*, Jun Tang, MD, FANZCA, MD{dagger}, Tom Webb, MD{dagger}, John E. Forestner, MD*, Nancy B. Greilich, MD*, and Larry L. Duffy, MD*

Departments of Anesthesiology and Pain Management, *University of Texas Southwestern Medical Center at Dallas, Texas; and {dagger}Cedars Sinai Medical Center in Los Angeles, California

Address correspondence to Paul F. White, PhD, MD, FANZCA, Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, F2.208, Dallas, TX 75235-9068. Address e-mail to paul.white{at}email .swmed.edu.

We evaluated the spontaneous recovery characteristics of rapacuronium during desflurane-, sevoflurane-, or propofol-based anesthesia in 51 consenting women undergoing laparoscopic tubal ligation procedures. After the induction of the anesthesia with standardized doses of propofol and fentanyl, 1.5 mg/kg IV rapacuronium was administered to facilitate tracheal intubation. Patients were randomized to receive either 1 minimum alveolar anesthetic concentration of desflurane, 1 minimum alveolar concentration of sevoflurane, or 100 µg · kg-1 · min-1 propofol infusion in combination with 66% nitrous oxide in oxygen for maintenance of anesthesia. Neuromuscular blockade was monitored at the wrist by using electromyography. The degree of maximum blockade and the times for first twitch recovery (T1) to 5%, 25%, 50%, 75%, and 90%, as well as the recovery index, were similar in all three anesthetic groups. However, recovery times for the train-of-four ratio to achieve 0.7 and 0.8 were significantly longer with desflurane (44.4 ± 18.9 and 53.5 ± 22.4 min) and sevoflurane (44.8 ± 15.1 and 53.2 ± 15.8 min) compared with propofol (31.8 ± 5.3 and 36.5 ± 6.5 min). Eight patients (16%) required a maintenance dose of 0.5 mg/kg rapacuronium and reversal of rapacuronium residual block occurred in three (6%) patients. We conclude that spontaneous recovery after an intubating dose of 1.5 mg/kg rapacuronium was significantly prolonged by both desflurane and sevoflurane compared with propofol-based anesthesia. Routine monitoring of neuromuscular activity is recommended even when a single bolus dose of rapacuronium is administered during ambulatory anesthesia.

Implications: When administered for laparoscopic surgery, the duration of action of an intubating dose of rapacuronium was prolonged 40%–50% by desflurane and sevoflurane, respectively, (versus propofol). Monitoring recovery of neuromuscular blockade produced by rapacuronium is particularly important when desflurane or sevoflurane is administered to ensure that an adequate recovery (train-of-four >= 0.8) is achieved by the end of anesthesia.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
M. Paul, C. H. Kindler, R. M. Fokt, M. J. Dresser, N. C. J. Dipp, and C. S. Yost
The Potency of New Muscle Relaxants on Recombinant Muscle-Type Acetylcholine Receptors
Anesth. Analg., March 1, 2002; 94(3): 597 - 603.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
P. F. White
Editorial II: Rapacuronium: why did it fail as a replacement for succinylcholine?
Br. J. Anaesth., February 1, 2002; 88(2): 163 - 165.
[Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
T. M. Hemmerling, J. Schuettler, and H. Schwilden
Desflurane reduces the effective therapeutic infusion rate (ETI) of cisatracurium more than isoflurane, sevoflurane, or propofol : [Le desflurane, compare a l'isoflurane, au sevoflurane ou au propofol, reduit davantage la vitesse de perfusion therapeutique utile (PTU) du cisatracurium]
Can J Anesth, June 1, 2001; 48(6): 532 - 537.
[Abstract] [Full Text]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2000 by the International Anesthesia Research Society.